(Q59275946)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

editorial

0 references

title

Immune cells in the melanoma microenvironment hold information for prediction of the risk of recurrence and response to treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Viviana Vallacchi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Chiara Castelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Licia Rivoltini

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

Monica Rodolfo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

publication date

10 June 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

20 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

volume

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

page(s)

643-646

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

Immune reactions in benign and malignant melanocytic lesions: lessons for immunotherapy

20 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

The early antitumor immune response is necessary for tumor growth: Re-visiting Prehn's hypothesis in the human melanoma system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Exploiting the curative potential of adoptive T-cell therapy for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Checkpoint modulation in melanoma: an update on ipilimumab and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Model predicting survival in stage I melanoma based on tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Tumor-infiltrating lymphocyte grade in primary melanomas is independently associated with melanoma-specific survival in the population-based genes, environment and melanoma study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Tumour-infiltrating lymphocytes and melanoma tumorigenesis: an insight

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Towards the introduction of the 'Immunoscore' in the classification of malignant tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Prediction of response to anticancer immunotherapy using gene signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

BRAF mutation, NRAS mutation, and the absence of an immune-related expressed gene profile predict poor outcome in patients with stage III melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Review and cross-validation of gene expression signatures and melanoma prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Accumulation of regulatory T cells in sentinel lymph nodes is a prognostic predictor in patients with node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Profile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Altered local and systemic immune profiles underlie lymph node metastasis in breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

Transcriptional profiling of melanoma sentinel nodes identify patients with poor outcome and reveal an association of CD30(+) T lymphocytes with progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737159.2014.928206

10.1586/14737159.2014.928206

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24914691%20AND%20SRC:MED&resulttype=core&format=json

20 March 2020

1 reference